InvestorsHub Logo
Followers 0
Posts 1996
Boards Moderated 0
Alias Born 07/04/2003

Re: None

Tuesday, 04/08/2014 10:09:45 AM

Tuesday, April 08, 2014 10:09:45 AM

Post# of 474
Engineered, zinc finger domain–containing recombinases for site-specific delivery of therapeutic genes
An engineered recombinase could enable nontoxic, site-specific delivery of therapeutic genes to the human genome. Further details on the research, next steps and licensing status are discussed in the article.

http://www.nature.com/scibx/journal/v7/n13/full/scibx.2014.383.html



Do not rely upon information I provide to make investment decisions.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SGMO News